Zobrazeno 1 - 10
of 93
pro vyhledávání: '"Heini Lassus"'
Publikováno v:
PLoS ONE, Vol 16, Iss 6, p e0253270 (2021)
BackgroundEndometriosis is associated with increased risk of clear cell ovarian cancer and has even suggested being an etiological factor for this cancer. Association between endometriosis and extraovarian clear cell cancers is unclear. This study ai
Externí odkaz:
https://doaj.org/article/981837f5440141d8a82ac33bf75909ca
Autor:
Víctor Cervera-Carrascón, Mikko Siurala, Riikka Havunen, Sadia Zafar, Tanja de Gruijl, Anna Kanerva, João Manuel Santos, Camilla Heiniö, Dafne C A Quixabeira, Ralf Butzow, Heini Lassus
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss 1 (2020)
Background Ovarian cancers often contain significant numbers of tumor-infiltrating lymphocytes (TILs) that can be readily harnessed for adoptive T-cell therapy (ACT). However, the immunosuppressive ovarian tumor microenvironment and lack of tumor rea
Externí odkaz:
https://doaj.org/article/d193213f116c4daaa180c10d3d4c57c6
Autor:
Shan Deng, Xiaojun Yang, Heini Lassus, Shun Liang, Sippy Kaur, Qunrui Ye, Chunsheng Li, Li-Ping Wang, Katherine F Roby, Sandra Orsulic, Denise C Connolly, Youcheng Zhang, Kathleen Montone, Ralf Bützow, George Coukos, Lin Zhang
Publikováno v:
PLoS ONE, Vol 5, Iss 4, p e10277 (2010)
Aldehyde dehydrogenase isoform 1 (ALDH1) has been proved useful for the identification of cancer stem cells. However, our knowledge of the expression and activity of ALDH1 in common epithelial cancers and their corresponding normal tissues is still l
Externí odkaz:
https://doaj.org/article/ea58fb339551409982e852249ac192dc
Autor:
Sanna Pikkusaari, Manuela Tumiati, Anni Virtanen, Jaana Oikkonen, Yilin Li, Fernando Perez-Villatoro, Taru Muranen, Matilda Salko, Kaisa Huhtinen, Anna Kanerva, Heidi Koskela, Johanna Tapper, Riitta Koivisto-Korander, Titta Joutsiniemi, Ulla-Maija Haltia, Heini Lassus, Sampsa Hautaniemi, Anniina Färkkilä, Johanna Hynninen, Sakari Hietanen, Olli Carpén, Liisa Kauppi
Publikováno v:
Clinical Cancer Research. :OF1-OF14
Purpose: Deficiency in homologous recombination (HR) repair of DNA damage is characteristic of many high-grade serous ovarian cancers (HGSC). It is imperative to identify patients with homologous recombination–deficient (HRD) tumors as they are mos
Autor:
Astrid Murumägi, Daniela Ungureanu, Suleiman Khan, Mariliina Arjama, Katja Välimäki, Aleksandr Ianevski, Philipp Ianevski, Rebecka Bergström, Alice Dini, Anna Kanerva, Riitta Koivisto-Korander, Johanna Tapper, Heini Lassus, Mikko Loukovaara, Andrus Mägi, Akira Hirasawa, Daisuke Aoki, Vilja Pietiäinen, Teijo Pellinen, Ralf Bützow, Tero Aittokallio, Olli Kallioniemi
Publikováno v:
British Journal of Cancer. 128:678-690
Funding Information: This study was supported by grants from the Academy of Finland (grants 278741, 313267, 326238, 333583, 313267, 326238, and 344698), Academy of Finland Centre of Excellence for Translational Cancer Biology (grant 271845), Cancer S
Autor:
Jonna Similä-Maarala, Piret Soovares, Annukka Pasanen, Terhi Ahvenainen, Pia Vahteristo, Ralf Bützow, Heini Lassus
Publikováno v:
Gynecologic Oncology. 165:577-584
Publisher Copyright: © 2022 The Authors Background: Clear cell and endometrioid ovarian carcinomas (OCC and OEC, respectively) have a presumed origin in endometriosis and share molecular alterations with each other and with their endometrial counter
Autor:
Jukka Westermarck, Jeroen Pouwels, Olli Carpen, Ari Ristimäki, Denise C. Connolly, Teemu D. Laajala, Tiina Arsiola, Katja Kaipio, Caj Haglund, Ralf Butzow, Heini Lassus, Camilla Böckelman, Tove J. Grönroos, Kaisa Huhtinen, Umar Butt, Anna N. Cvrljevic
Supplementary Figure from Ovarian Cancers with Low CIP2A Tumor Expression Constitute an APR-246–Sensitive Disease Subtype
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::352a5a671124927daa8491821123b49c
https://doi.org/10.1158/1535-7163.22523778
https://doi.org/10.1158/1535-7163.22523778
Autor:
Jukka Westermarck, Jeroen Pouwels, Olli Carpen, Ari Ristimäki, Denise C. Connolly, Teemu D. Laajala, Tiina Arsiola, Katja Kaipio, Caj Haglund, Ralf Butzow, Heini Lassus, Camilla Böckelman, Tove J. Grönroos, Kaisa Huhtinen, Umar Butt, Anna N. Cvrljevic
Identification of ovarian cancer patient subpopulations with increased sensitivity to targeted therapies could offer significant clinical benefit. We report that 22% of the high-grade ovarian cancer tumors at diagnosis express CIP2A oncoprotein at lo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::208942602e77502000159c1ec45d3a15
https://doi.org/10.1158/1535-7163.c.6543912.v1
https://doi.org/10.1158/1535-7163.c.6543912.v1
Autor:
Jukka Westermarck, Jeroen Pouwels, Olli Carpen, Ari Ristimäki, Denise C. Connolly, Teemu D. Laajala, Tiina Arsiola, Katja Kaipio, Caj Haglund, Ralf Butzow, Heini Lassus, Camilla Böckelman, Tove J. Grönroos, Kaisa Huhtinen, Umar Butt, Anna N. Cvrljevic
Supplementary Table from Ovarian Cancers with Low CIP2A Tumor Expression Constitute an APR-246–Sensitive Disease Subtype
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1966dc26b2af84ba180d71f6034d3590
https://doi.org/10.1158/1535-7163.22523769
https://doi.org/10.1158/1535-7163.22523769
Autor:
Jukka Westermarck, Jeroen Pouwels, Olli Carpen, Ari Ristimäki, Denise C. Connolly, Teemu D. Laajala, Tiina Arsiola, Katja Kaipio, Caj Haglund, Ralf Butzow, Heini Lassus, Camilla Böckelman, Tove J. Grönroos, Kaisa Huhtinen, Umar Butt, Anna N. Cvrljevic
Supplementary Data from Ovarian Cancers with Low CIP2A Tumor Expression Constitute an APR-246–Sensitive Disease Subtype
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3b4996de6c859a3250132f93e0dd5998
https://doi.org/10.1158/1535-7163.22523976
https://doi.org/10.1158/1535-7163.22523976